Showing results (1831-1840 of 2,044) with videos related to
Sort By:
Pageof 205
Nature Communications|November 22, 2019
Integrin-linked kinase controls retinal angiogenesis and is linked to Wnt signaling and exudative vitreoretinopathyHongryeol Park, Hiroyuki Yamamoto, Lucas Mohn, et al.Experimental Hematology|July 5, 2001
Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytesS Kadereit, M M Kozik, G R Junge, et al.British Journal of Cancer|October 21, 2020
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemiaTimothy M Barrow, Sirintra Nakjang, Fadhel Lafta, et al.Journal of Clinical Pharmacology|May 20, 2020
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A InhibitionXia Li, Lisa Junge, Max Taubert, et al.European Journal of Pediatrics|January 14, 2022
Spinal pain in childhood: prevalence, trajectories, and diagnoses in children 6 to 17 years of ageJeffrey J Hébert, Amber M Beynon, Bobby L Jones, et al.Plos One|November 14, 2014
High variability in oral glucose tolerance among 1,128 patients with cystic fibrosis: a multicenter screening studyNicole Scheuing, Reinhard W Holl, Gerd Dockter, et al.British Journal of Sports Medicine|March 13, 2014
Injury and illness definitions and data collection procedures for use in epidemiological studies in Athletics (track and field): consensus statementToomas Timpka, Juan-Manuel Alonso, Jenny Jacobsson, et al.Clinical and Translational Science|May 18, 2024
First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitorEwa Gatlik, Beata Mehes, Emilie Voltz, et al.Angewandte Chemie (International Ed. in English)|April 22, 2017
Non-Pincer-Type Manganese Complexes as Efficient Catalysts for the Hydrogenation of EstersRobbert van Putten, Evgeny A Uslamin, Marcel Garbe, et al.Transplantation|July 8, 2015
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter StudyLutz Fischer, Faouzi Saliba, Gernot M Kaiser, et al.Pageof 205